Publications

1. Babu R, Van Dyke DL, Bhattacharya S, Dev VG, Liu M, Kwon M, Gu G, Koduru P, Rao N, Williamson C, Fuentes E, Fuentes S, Papa S, Kopuri S, Lal V. A rapid and reliable chromosome analysis method for products of conception using interphase nuclei. Mol Genet Genomic Med. 2018 Mar 24 [Epub ahead of print]
   View PubMed
2. Babu R, Van Dyke DL, Dev VG, Koduru P, Rao N, Mitter NS, Liu M, Fuentes E, Fuentes S, Papa S. Interphase Chromosome Profiling: A Method for Conventional Banded Chromosome Analysis Using Interphase Nuclei. Arch Pathol Lab Med. 2018 Feb; 142 (2):213-228 Epub 2017 Oct 05
   View PubMed
3. Swanson AA, Giannini C, Folpe AL, Van Dyke DL, Amrami KK, Michalak WA, Vaubel RA. Low-grade fibromyxoid sarcoma arising within the median nerve. Neuropathology. 2018 Jan 3 Epub 2018 Jan 03
   View PubMed
4. Dias A, Al-Kali A, Van Dyke D, Niederwieser D, Vucinic V, Lemke J, Muller C, Schwind S, Teichmann AC, Bakken R, Burns LJ, Litzow M. Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor-Derived Constitutional Abnormality. Biol Blood Marrow Transplant. 2017 Sep; 23 (9):1582-1587 Epub 2017 May 23
   View PubMed
5. Ding W, LaPlant BR, Call TG, Parikh SA, Leis JF, He R, Shanafelt TD, Sinha S, Le-Rademacher J, Feldman AL, Habermann TM, Witzig TE, Wiseman GA, Lin Y, Asmus E, Nowakowski GS, Conte MJ, Bowen DA, Aitken CN, Van Dyke DL, Greipp PT, Liu X, Wu X, Zhang H, Secreto CR, Tian S, Braggio E, Wellik LE, Micallef I, Viswanatha DS, Yan H, Chanan-Khan AA, Kay NE, Dong H, Ansell SM. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood. 2017 Jun 29; 129 (26):3419-3427 Epub 2017 Apr 19
   View PubMed
6. Bieber FR, Cherry AM, Emanuel BS, Francke U, Hoyme HE, Jackson LG, Morton CC, Muenke M, Powell CM, Punnett HH, Rao PN, Schwartz S, Stevenson RE, Van Dyke DL. Commentary on the decision of the American Board of Medical Genetics and Genomics to create a 24-month specialty of Laboratory Genetics and Genomics. Genet Med 2017 Mar; 19 (3):294-296 Epub 2016 Nov 17
   View PubMed
7. He R, Wiktor AE, Durnick DK, Kurtin PJ, Van Dyke DL, Tefferi A, Patnaik MS, Ketterling RP, Hanson CA. Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes. Am J Clin Pathol. 2016 Jul; 146 (1):86-94 Epub 2016 June 27
   View PubMed
8. Van Dyke DL, Werner L, Rassenti LZ, Neuberg D, Ghia E, Heerema NA, Dal Cin P, Dell Aquila M, Sreekantaiah C, Greaves AW, Kipps TJ, Kay NE. The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience. Br J Haematol. 2016 Apr; 173: (1)105-13.
   View PubMed
9. Parikh SA, Leis JF, Chaffee KG, Call TG, Hanson CA, Ding W, Chanan-Khan AA, Bowen D, Conte M, Schwager S, Slager SL, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes. Cancer. 2015 Sep 1; 121: (17)2883-91.
   View PubMed
10. He R, Wiktor AE, Hanson CA, Ketterling RP, Kurtin PJ, Van Dyke DL, Litzow MR, Howard MT, Reichard KK. Conventional karyotyping and fluorescence in situ hybridization: an effective utilization strategy in diagnostic adult acute myeloid leukemia. Am J Clin Pathol. 2015 Jun; 143 (6):873-8
    View PubMed
11. Ojha J, Ayres J, Secreto C, Tschumper R, Rabe K, Van Dyke D, Slager S, Shanafelt T, Fonseca R, Kay NE, Braggio E. Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia. Blood. 2015 Jan 15; 125: (3)492-8.
    View PubMed
12. Aypar U, Reichard KK, Waltman LA, Van Dyke DL. Isolated trisomy 2 in bone marrows of patients with suspected hematopoietic malignancies. Cancer Genet. 2014 Apr; 207: (4)124-7.
    View PubMed
13. Geiersbach KB, Gardiner AE, Wilson A, Shetty S, Bruyere H, Zabawski J, Saxe DF, Gaulin R, Williamson C, Van Dyke DL. Subjectivity in chromosome band-level estimation: a multicenter study. Genet Med. 2014 Feb; 16: (2)170-5.
    View PubMed
14. Greipp PT, Smoley SA, Viswanatha DS, Frederick LS, Rabe KG, Sharma RG, Slager SL, Van Dyke DL, Shanafelt TD, Tschumper RC, Zent CS. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis. Br J Haematol. 2013 Nov; 163: (3)326-33.
    View PubMed
15. Waltman LA, Eckel-Passow JE, Sharma RG, Van Dyke DL. Advanced maternal age in polyploidy with concurrent aneuploidy. Am J Med Genet A. 2013 May; 161A(5):1200-2. Epub 2013 Mar 29.
    View PubMed
16. Crotti L, Tester DJ, White WM, Bartos DC, Insolia R, Besana A, Kunic JD, Will ML, Velasco EJ, Bair JJ, Ghidoni A, Cetin I, Van Dyke DL, Wick MJ, Brost B, Delisle BP, Facchinetti F, George AL, Schwartz PJ, Ackerman MJ. Long QT syndrome-associated mutations in intrauterine fetal death. JAMA. 2013 Apr 10; 309(14):1473-82.
    View PubMed
17. Hussain FT, Nguyen EP, Raza S, Knudson R, Pardanani A, Hanson CA, Van Dyke, Tefferi A. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications. Am J Hematol. 2012 Jul; 87(7):684-6. Epub 2012 May 06.
    View PubMed
18. Cherry AM, Slovak ML, Campbell LJ, Chun K, Eclache V, Haase D, Haferlach C, Hildebrandt B, Iqbal AM, Jhanwar SC, Ohyashiki K, Sole F, Vandenberghe P, VanDyke DL, Zhang Y, Dewald GW. Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia? Leuk Res. 2012 Jul; 36(7):832-40. Epub 2012 Apr 25.
    View PubMed
19. Hutchens C, Ketterling RP, Van Dyke. When are apparently non-clonal abnormalities in bone marrow chromosome studies actually clonal? Cancer Genet. 2012 Jul-Aug; 205(7-8):405-9.
    View PubMed
20. Hofherr SE, Wiktor AE, Kipp BR, Dawson DB, Van Dyke DL. Clinical diagnostic testing for the cytogenetic and molecular causes of male infertility: the Mayo Clinic experience. J Assist Reprod Genet. 2011 Nov; 28(11):1091-8. Epub 2011 Sep 13.
    View PubMed
21. Tefferi A, Jimma T, Gangat N, Vaidya R, Begna KH, Hanson CA, Van Dyke DL, Caramazza D, Pardanani A. Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients. Blood. 2011 Oct 27; 118(17):4595-8. Epub 2011 Aug 31.
    View PubMed
22. Wiktor AE, Van Dyke, Hodnefield JM, Eckel-Passow J, Hanson CA. The significance of isolated Y chromosome loss in bone marrow metaphase cells from males over age 50 years. Leuk Res. 2011 Oct; 35(10):1297-300. Epub 2011 Jun 23.
    View PubMed
23. Brothman AR, Dolan MM, Goodman BK, Park JP, Persons DL, Saxe DF, Tepperberg JH, Tsuchiya KD, Van Dyke DL, Wilson KS, Wolff DJ, Theil KS. College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis. Genet Med. 2011 Sep; 13(9):765-9.
    View PubMed
24. Vaidya R, Caramazza D, Begna KH, Gangat N, Van Dyke, Hanson CA, Pardanani A, Tefferi A. Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survival. Blood. 2011 May 26; 117(21):5612-5. Epub 2011 Mar 30.
    View PubMed
25. Raza S, TaherNazerHussain F, Patnaik M, Knudson R, Van Dyke, Tefferi A. Autosomal monosomies among 24,262 consecutive cytogenetic studies: prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities. Am J Hematol. 2011 Apr; 86(4):353-6.
    View PubMed
26. Patnaik MM, Hanson CA, Hodnefield JM, Knudson R, Van Dyke DL, Tefferi A. Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia. 2011 Feb; 25(2):266-70. Epub 2010 Nov 12.
    View PubMed
27. Gangat N, Caramazza D, Vaidya R, George G, Begna K, Schwager S, Van Dyke, Hanson C, Wu W, Pardanani A, Cervantes F, Passamonti F, Tefferi A. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol. 2011 Feb 1; 29(4):392-7. Epub 2010 Dec 13.
    View PubMed
28. Wang RW, Olson RM, Spurbeck JL, Bertling KM, Mitchell EB, Van Dyke DL. ISCN (2009)-A Reference Guide. J Assoc Genet Technol. 2011; 37(2):85-94.
    
29. Caramazza D, Begna KH, Gangat N, Vaidya R, Siragusa S, Van Dyke, Hanson C, Pardanani A, Tefferi A. Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients. Leukemia. 2011 Jan; 25(1):82-8. Epub 2010 Oct 14.
    View PubMed
30. Heerema NA, Byrd JC, Dal Cin, Dell' Aquila, Koduru PR, Aviram A, Smoley SA, Rassenti LZ, Greaves AW, Brown JR, Rai KR, Kipps TJ, Kay NE, Van Dyke. Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study. Cancer Genet Cytogenet. 2010 Dec; 203(2):134-40.
    View PubMed
31. Smoley SA, Van Dyke DL, Kay NE, Heerema NA, Dell' Aquila ML, Dal Cin P, Koduru P, Aviram A, Rassenti L, Byrd JC, Rai KR, Brown JR, Greaves AW, Eckel-Passow J, Neuberg D, Kipps TJ, Dewald GW. Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium. Cancer Genet Cytogenet. 2010 Dec; 203(2):141-8.
    View PubMed
32. Kay NE, Eckel-Passow JE, Braggio E, Vanwier S, Shanafelt TD, Van Dyke DL, Jelinek DF, Tschumper RC, Kipps T, Byrd JC, Fonseca R. Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy. Cancer Genet Cytogenet. 2010 Dec; 203: (2)161-8.
    View PubMed
33. Sukov WR, Ketterling RP, Wei S, Monaghan K, Blunden P, Mazzara P, Raghavan R, Oliviera AM, Wiktor AE, Keeney GL, Van Dyke. Nearly identical near-haploid karyotype in a peritoneal mesothelioma and a retroperitoneal malignant peripheral nerve sheath tumor. Cancer Genet Cytogenet. 2010 Oct 15; 202(2):123-8.
    View PubMed
34. Van Dyke DL, Shanafelt TD, Call TG, Zent CS, Smoley SA, Rabe KG, Schwager SM, Sonbert JC, Slager SL, Kay NE. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia. Br J Haematol. 2010 Feb; 148: (4)544-50.
    View PubMed
35. Hussein K, Pardanani AD, Van Dyke, Hanson CA, Tefferi A. International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis. Blood. 2010 Jan 21; 115(3):496-9. Epub 2009 Nov 09.
    View PubMed
36. Wolff DJ, Van Dyke DL, Powell CM, Working Group of the ACMG Laboratory Quality Assurance Committee. Laboratory guideline for Turner syndrome. Genet Med. 2010 Jan; 12(1):52-5.
    View PubMed
37. Deng XX, Nguyen DK, Hansen RS, Van Dyke DL, Gartler SM, Disteche CM. Dosage regulation of the active X chromosome in human triploid cells. PLoS Genet. 2009 Dec; 5(12).
    View PubMed
38. Dewald GW, Smyrk TC, Thorland EC, McWilliams RR, Van Dyke DL, Keefe JG, Belongie KJ, Smoley SA, Knutson DL, Fink SR, Wiktor AE, Petersen GM. Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas. Mayo Clin Proc. 2009 Sep; 84: (9)801-10.
    View PubMed
39. Tam CS, Shanafelt TD, Wierda WG, Abruzzo LV, Van Dyke DL, O'Brien S, Ferrajoli A, Lerner SA, Lynn A, Kay NE, Keating MJ. De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience. Blood. 2009 Jul 30; 114(5):957-64. Epub 2009 May 4
    View PubMed
40. Fink SR, Belongie KJ, Paternoster SF, Smoley SA, Pardanani AD, Tefferi A, Van Dyke DL, Ketterling RP. Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC2 deletion, FIP1L1/PDGFRA fusion and PDGFRA translocations. Leuk Res. 2009 Jun; 33: (6)843-6.
    View PubMed
41. Hussein K, Van Dyke DL, Tefferi A. Conventional cytogenetics in myelofibrosis: literature review and discussion. Eur J Haematol. 2009 May; 82(5):329-38. Epub 2009 Jan 9
    View PubMed
42. Hussein K, Huang J, Lasho T, Pardanani A, Mesa RA, Williamson CM, Ketterling RP, Hanson CA, Van Dyke DL, Tefferi A. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis. Eur J Haematol. 2009 Apr; 82(4):255-9. Epub 2008 Feb 10
    View PubMed
43. Wiktor AE, Bender G, Van Dyke DL. Identification of sex chromosome mosaicism: is analysis of 20 metaphase cells sufficient? Am J Med Genet A. 2009 Feb; 149A(2):257-9.
    View PubMed
44. Hussein K, Ketterling RP, Dewald GW, Van Dyke DL, Mesa R, Hanson CA, Tefferi A. Peripheral blood cytogenetic studies in myelofibrosis: overall yield and comparison with bone marrow cytogenetic studies. Leuk Res. 2008 Oct; 32(10):1597-600. Epub 2008 Feb 1
    View PubMed
45. Hussein K, Ketterling RP, Hulshizer RL, Kuffel DG, Wiktor AE, Hanson CA, Tefferi A, Van Dyke DL. Peripheral blood cytogenetic studies in hematological neoplasms: predictors of obtaining metaphases for analysis. Eur J Haematol. 2008 Apr; 80(4):318-21. Epub 2007 Dec 18
    View PubMed
46. Hanson CA, Steensma DP, Hodnefield JM, Nguyen PL, Hoyer JD, Viswanatha DS, Zou Y, Knudson RA, Van Dyke DL, Ketterling RP. Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance. Am J Clin Pathol. 2008 Mar; 129(3):478-85.
    View PubMed
47. Bowen DA, Call TG, Jenkins GD, Zent CS, Schwager SM, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD. Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features. Leuk Lymphoma. 2007 Dec; 48(12):2412-7.
    View PubMed
48. Adeyinka A, Smoley S, Fink S, Sanchez J, Van Dyke DL, Dewald G. Isochromosome (X)(p10) in hematologic disorders: FISH study of 14 new cases show three types of centromere signal patterns. Cancer Genet Cytogenet. 2007 Nov; 179(1):25-30.
    View PubMed
49. Ida CM, Rolig KA, Hulshizer RL, Van Dyke DL, Randolph JL, Jenkins RB, Nascimento AG, Oliveira AM. Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality. Cancer Genet Cytogenet. 2007 Sep; 177(2):139-42.
    View PubMed
50. Micale MA, Schran D, Emch S, Kurczynski TW, Rahman N, Van Dyke DL. Mosaic variegated aneuploidy without microcephaly: Implications for cytogenetic diagnosis. Am J Med Genet A. 2007 Aug 15; 143A(16):1890-3.
    View PubMed
51. Zou YS, Van Dyke DL, Ellison JW. Microarray comparative genomic hybridization and FISH studies of an unbalanced cryptic telomeric 2p deletion/16q duplication in a patient with mental retardation and behavioral problems. Am J Med Genet A. 2007 Apr 1; 143A(7):746-51.
    View PubMed
52. Zou YS, Van Dyke DL, Thorland EC, Chhabra HS, Michels VV, Keefe JG, Lega MA, Feely MA, Uphoff TS, Jalal SM. Mosaic ring 20 with no detectable deletion by FISH analysis: Characteristic seizure disorder and literature review. Am J Med Genet A. 2006 Aug 1; 140(15):1696-706.
    View PubMed
53. Zou YS, McGrann PS, Uphoff TS, Van Dyke DL. A case of mosaic supernumerary ring chromosome 15 with two copies of the segment 15p11.1-q14. Am J Med Genet A. 2006 Aug 1; 140(15):1663-8.
    View PubMed
54. Graf MD, Christ L, Mascarello JT, Mowrey P, Pettenati M, Stetten G, Storto P, Surti U, Van Dyke DL, Vance GH, Wolff D, Schwartz S. Redefining the risks of prenatally ascertained supernumerary marker chromosomes: a collaborative study. J Med Genet. 2006 Aug; 43(8):660-4.
    View PubMed
55. Fink SR, Smoley SA, Stockero KJ, Paternoster SF, Thorland EC, Van Dyke DL, Shanafelt TD, Zent CS, Call TG, Kay NE, Dewald GW. Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2006 Jun; 167(2):177-81.
    View PubMed
56. Stockero KJ, Fink SR, Smoley SA, Paternoster SF, Shanafelt TD, Call TG, Zent CS, Van Dyke DL, Kay NE, Dewald GW. Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2006 Apr 15; 166(2):152-6.
    View PubMed
57. Welch RA, Salem-Elgharib S, Wiktor AE, Van Dyke DL, Blessed WB. Operator experience and sample quality in genetic amniocentesis. Am J Obstet Gynecol. 2006 Jan; 194(1):189-91.
    View PubMed
58. Wiktor AE, Van Dyke DL, Stupca PJ, Ketterling RP, Thorland EC, Shearer BM, Fink SR, Stockero KJ, Majorowicz JR, Dewald GW. Preclinical validation of fluorescence in situ hybridization assays for clinical practice. Genet Med. 2006 Jan; 8(1):16-23.
    View PubMed
59. Wiktor AE, Stupca PJ, Van Dyke DL. USCN(2005) - A Reference Guide. J Assoc Genet Technol. 2006; 32(2):32-40.
    
60. Dewald GW, Therneau T, Larson D, Lee YK, Fink S, Smoley S, Paternoster S, Adeyinka A, Ketterling R, Van Dyke DL, Fonseca R, Kyle R. Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. Blood. 2005 Nov 15; 106: (10)3553-8.
    View PubMed
61. Wiktor AE, Van Dyke DL. Detection of low level sex chromosome mosaicism in Ullrich-Turner syndrome patients. Am J Med Genet Part A. 2005 Oct 15; 138A(3):259-61.
    View PubMed
62. Adeyinka A, Adams SA, Lorentz CP, Van Dyke DL, Jalal SM. Subtelomere deletions and translocations are frequently familial. Am J Med Genet Part A. 2005 May 15; 135A(1):28-35.
    View PubMed
63. Caudill SP, Van Dyke DL, Chen AT, Reidy JA, Ing PS, Schwartz S, Vance GH. Evaluating current policy for detecting mosaicism in amniotic fluid cultures: implications for current cell counting practices. Stat Med. 2005 Feb 28; 24(4):615-22.
    View PubMed
64. Coon SW, Savera AT, Zarbo RJ, Benninger MS, Chase GA, Rybicki BA, Van Dyke DL. Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma. Int J Cancer. 2004 Aug 20; 111(2):206-12.
    View PubMed
65. Wiktor A, Van Dyke DL. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma. Cancer Genet Cytogenet. 2004 Aug; 153(1):73-6.
    View PubMed
66. Zhang Y, Emmanuel N, Kamboj G, Chen J, Shurafa M, Van Dyke DL, Wiktor A, Rowley JD. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22). Genes Chrom Cancer. 2004 Aug; 40(4):365-70.
    View PubMed
67. Asamoah A, Nwankwo M, Kumar SP, Ezhuthachan SG, Van Dyke DL. Proximal chromosome 8q deletion in a boy with femoral bifurcation and other multiple congenital anomalies. Am J Med Genet Part A. 2004 May 15; 127(1):65-8.
    View PubMed
68. Wiktor A, Van Dyke DL. FISH analysis helps identify low-level mosaicism in Ullrich-Turner syndrome patients. Genet Med. 2004 May-Jun; 6(3):132-5.
    View PubMed
69. Kuriakose P, Perveen N, Maeda K, Wiktor A, Van Dyke DL. Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia. Cancer Genet Cytogenet. 2004 Apr 15; 150(2):156-8.
    View PubMed
70. Raitanen M, Worsham MJ, Lakkala T, Carey TE, Van Dyke DL, Grenman R, Klemi P, Rantanen V, Isola J, Grenman S. Characterization of 10 vulvar carcinoma cell lines by karyotyping, comparative genomic hybridization and flow cytometry. Gynecol Oncol. 2004 Apr; 93(1):155-63.
    View PubMed
71. Salama ME, Shah V, Lebel RR, VanDyke DL. Aberrant nuclear projections of neutrophils in trisomy 13. Arch Path Lab Med. 2004 Feb; 128(2):243-4.
    View PubMed
72. Rybicki BA, Savera AT, Gomez JA, Patel SC, Ballard NE, Benninger MS, Zarbo RJ, Van Dyke DL. Allelic loss and tumor pathology in head and neck squamous cell carcinoma. Mod Pathol. 2003 Oct; 16(10):970-9.
    View PubMed
73. Van Dyke DL, Wiktor A. Monosomy 21 in hematologic diseases. Cancer Genet Cytogenet. 2003 Apr 15; 142(2):137-41.
    View PubMed
74. Asamoah A, Decker AB, Wiktor A, Van Dyke DL. Child with De Novo t(1;6)(p22.1;p22.1) translocation and features of ectodermal dysplasia with hypodontia and developmental delay. Am J Med Genet Part A. 2003 Apr 1; 118(1):82-5.
    View PubMed
75. Wiktor A, Linden MD, Van Dyke DL. HER-2/neu testing in breast cancer. J Assoc Genet Technol. 2003; 29:152-5.
    View PubMed
76. Monaghan KG, Wiktor A, Van Dyke DL. Diagnostic testing for Prader-Willi syndrome and Angelman syndrome: a cost comparison. Genet Med. 2002 Nov-Dec; 4(6):448-50.
    View PubMed
77. Wilson SC, Susman M, Bain S, Wohlferd M, Van Dyke DL, Daniel A, White B, Gardner RJ. Isochromosome 5p mosaicism at prenatal diagnosis: observations and outcomes in six cases at chorionic villus sampling and one at amniocentesis. Prenat Diagn. 2002 Aug; 22(8):681-5.
    View PubMed
78. Satinover DL, Vance GH, Van Dyke DL, Schwartz S. Cytogenetic analysis and construction of a BAC contig across a common neocentromeric region from 9p. Chromosoma. 2001 Aug; 110(4):275-83.
    View PubMed
79. Wiktor A, Feldman GL, Bawle EV, Czarnecki P, Conard JV, Van Dyke DL. Deletion of 2q37 and duplication of 10q24: two cases in the same family and review of the literature. Ann Genet. 2001 Jul-Sep; 44(3):129-34.
    View PubMed
80. Barnabas N, Shurafa M, Van Dyke DL, Wolman SR, Clark D, Worsham MJ. Significance of p53 mutations in patients with chronic lymphocytic leukemia: a sequential study of 30 patients. Cancer. 2001 Jan 15; 91(2):285-93.
    View PubMed
81. Manji S, Roberson JR, Wiktor A, Vats S, Rush P, Diment S, Van Dyke DL. Prenatal diagnosis of 22q11.2 deletion when ultrasound examination reveals a heart defect. Genet Med. 2001 Jan-Feb; 3(1):65-6.
    View PubMed
82. Teshima I, Bawle EV, Weksberg R, Shuman C, Van Dyke DL, Schwartz S. Analphoid 3qter markers. Am J Med Genet. 2000 Sep 11; 94(2):113-9.
    View PubMed
83. Baumgartner BJ, Shurafa M, Terebelo H, Tapazoglou E, Van Dyke DL. Trisomy 15, sex chromosome loss, and hematological malignancy. Cancer Genet Cytogenet. 2000 Mar; 117(2):132-5.
    View PubMed
84. Wallerstein R, Yu MT, Neu RL, Benn P, Lee Bowen C, Crandall B, Disteche C, Donahue R, Harrison B, Hershey D, Higgins RR, Jenkins LS, Jackson-Cook C, Keitges E, Khodr G, Lin CC, Luthardt FW, Meisner L, Mengden G, Patil SR, Rodriguez M, Sciorra LJ, Shaffer LG, Stetten G, Van Dyke DL, Wang H. Common trisomy mosaicism diagnosed in amniocytes involving chromosomes 13, 18, 20 and 21: karyotype-phenotype correlations. Prenat Diagn. 2000 Feb; 20(2):103-22.
    View PubMed
85. Wiktor A, Rybicki BA, Piao ZS, Shurafa M, Barthel B, Maeda K, Van Dyke DL. Clinical significance of Y chromosome loss in hematologic disease. Genes Chrom Cancer. 2000 Jan; 27(1):11-6.
    View PubMed
86. Ing PS, Van Dyke DL, Caudill SP, Reidy JA, Bice G, Bieber FR, Buchanan PD, Carroll AJ, Cheung SW, DeWald G, Donahue RP, Gardner HA, Higgins J, Hsu LYF, Jamehdor M, Keitges EA, Laundon CH, Luthardt FW, Mascarello J, May KM, Meck JM, Morton C, Patil S, Peakman D, Pettenati MJ, Chen ATL, et al. Detection of mosaicism in amniotic fluid cultures: a CYTO2000 collaborative study. Genet Med. 1999 Mar-Apr; 1(3):94-7.
    View PubMed
87. Tsai CH, Van Dyke DL, Feldman GL. Child with velocardiofacial syndrome and del (4)(q34.2): another critical region associated with a velocardiofacial syndrome-like phenotype. Am J Med Genet. 1999 Feb 12; 82(4):336-9.
    View PubMed
88. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS, Van Dyke DL. Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridisation. Mol Pathol. 1999 Feb; 52(1):42-6.
    View PubMed
89. Berend SA, Feldman GL, McCaskill C, Czarnecki P, Van Dyke DL, Shaffer LG. Investigation of two cases of paternal disomy 13 suggests timing of isochromosome formation and mechanisms leading to uniparental disomy. Am J Med Genet. 1999 Jan 29; 82(3):275-81.
    View PubMed
90. Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, Guerra R, Kushner H, Schwartz S, Sybert VP, Van Dyke DL, Ross JL. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet. 1998 Dec; 63(6):1757-66.
    View PubMed
91. Monaghan KG, Van Dyke DL, Feldman GL. Prader-Willi-like syndrome in a patient with an Xq23q25 duplication. Am J Med Genet. 1998 Nov 16; 80(3):227-31.
    View PubMed
92. Pratt VM, Roberson JR, Weiss L, Van Dyke DL. Duplication 6q21q23 in two unrelated patients. Am J Med Genet. 1998 Nov 2; 80(2):112-4.
    View PubMed
93. Wiktor A, Puskorius R, Zubrickas K, Van Dyke DL. Sequential G-banding and fluorescent in situ hybridization on peripheral blood, bone marrow, and amniotic fluid samples. Am J Med Genet. 1998 Aug 27; 79(1):38-41.
    View PubMed
94. White WM, Willard HF, Van Dyke DL, Wolff DJ. The spreading of X inactivation into autosomal material of an x;autosome translocation: evidence for a difference between autosomal and X-chromosomal DNA.[erratum appears in Am J Hum Genet 1998 Oct;63(4):1252]. Am J Hum Genet. 1998 Jul; 63(1):20-8.
    View PubMed
95. Monaghan KG, Dennehy PJ, VanDyke DL, Weiss L. Bilateral Peter's anomaly in an infant with 49,XXXXY syndrome. J Pediatr Ophthalmol Strabismus. 1998 Mar-Apr; 35(2):112-3.
    View PubMed
96. Pearlstein RP, Benninger MS, Carey TE, Zarbo RJ, Torres FX, Rybicki BA, Van Dyke DL. Loss of 18q predicts poor survival in patients with squamous cell carcinoma of the head and neck. Genes Chromosomes & Cancer. 1998; 21:333-9.
    View PubMed
97. Monaghan KG, Van Dyke DL, Wiktor A, Feldman GL. Cytogenetic and clinical findings in a patient with a deletion of 16q23.1: first report of bilateral cataracts and a 16q deletion. Am J Med Genet. 1997 Dec 12; 73(2):180-3.
    View PubMed
98. Depinet TW, Zackowski JL, Earnshaw WC, Kaffe S, Sekhon GS, Stallard R, Sullivan BA, Vance GH, Van Dyke DL, Willard HF, Zinn AB, Schwartz S. Characterization of neo-centromeres in marker chromosomes lacking detectable alpha-satellite DNA. Hum Mol Genet. 1997 Aug; 6(8):1195-204.
    View PubMed
99. Wolff DJ, Gustashaw KM, Zurcher V, Ko L, White W, Weiss L, Van Dyke DL, Schwartz S, Willard HF. Deletions in Xq26.3-q27.3 including FMR1 result in a severe phenotype in a male and variable phenotypes in females depending upon the X inactivation pattern. Hum Genet. 1997 Aug; 100(2):256-61.
    View PubMed
100. Jones JW, Raval JR, Beals TF, Worsham MJ, Van Dyke DL, Esclamado RM, Wolf GT, Bradford CR, Miller T, Carey TE. Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas. Identification of 2 regions of loss--18q11.1-q12.3 and 18q21.1-q23. Arch Otolaryngol Head Neck Surg. 1997 Jun; 123(6):610-4.
     View PubMed
101. Hsu LY, Yu MT, Neu RL, Van Dyke DL, Benn PA, Bradshaw CL, Shaffer LG, Higgins RR, Khodr GS, Morton CC, Wang H, Brothman AR, Chadwick D, Disteche CM, Jenkins LS, Kalousek DK, Pantzar TJ, Wyatt P. Rare trisomy mosaicism diagnosed in amniocytes, involving an autosome other than chromosomes 13, 18, 20, and 21: karyotype/phenotype correlations. Prenat Diagn. 1997 Mar; 17(3):201-42.
     View PubMed
102. Carey TE, Frank CJ, Raval JR, Jones JW, McClatchey KD, Beals TF, Worsham MJ, Van Dyke DL. Identifying genetic changes associated with tumor progression in squamous cell carcinoma. Acta Otolaryngol Suppl (Stockh). 1997; 529: 229-32.
     View PubMed
103. Pearlstein RP, Benninger MS, Rybicki BA, Torres F, Van Dyke DL. Preliminary study of 18q loss of heterozygosity and poor survival in patients with stage III head and neck cancer. On-line Interact J Otolaryngol II: FA: 1997; 1-6.
     View PubMed
104. Kelker W, Van Dyke DL, Worsham MJ, Christopherson PL, James CD, Conlon MR, Carey TE. Loss of 18q and homozygosity for the DCC locus: possible markers for clinically aggressive squamous cell carcinoma. Anticancer Res. 1996 Jul-Aug; 16(4C):2365-72.
     View PubMed
105. Buchagen DL, Worsham MJ, Van Dyke DL, Carey TE. Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: Comparison with cytogenetic analysis. Head and Neck. 1996; 18:529-537.
     View PubMed
106. Hsu LY, Yu MT, Richkind KE, Van Dyke DL, Crandall BF, Saxe DF, Khodr GS, Mennuti M, Stetten G, Miller WA, Priest JH. Incidence and significance of chromosome mosaicism involving an autosomal structural abnormality diagnosed prenatally through amniocentesis: a collaborative study. Prenat Diagn. 1996 Jan; 16(1):1-28.
     View PubMed
107. Wolff DJ, Miller AP, Van Dyke DL, Schwartz S, Willard HF. Molecular definition of breakpoints associated with human Xq isochromosomes: implications for mechanisms of formation. Am J Hum Genet. 1996 Jan; 58(1):154-60.
     View PubMed
108. Wiktor A, Van Dyke DL. Cytogenetics nomenclature - a reference guide. Applied Cytogenetics. 1996; 22:24-9.
     View PubMed
109. Bischoff FZ, Zenger-Hain J, Moses D, Van Dyke DL, Shaffer LG. Mosaicism for trisomy 12: four cases with varying outcomes. Prenat Diagn. 1995 Nov; 15(11):1017-26.
     View PubMed
110. Scheuerle A, Zenger-Hain JL, Van Dyke DL, Ledbetter DH, Greenberg F, Shaffer LG. Replication banding and molecular studies of a mosaic, unbalanced dic(X;15)(Xpter-->Xq26.1::15p11-->15qter). Am J Med Genet. 1995 May 8; 56(4):403-8.
     View PubMed
111. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS, Van Dyke DL. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol. 1995 Mar; 26(3):251-61.
     View PubMed
112. Pettenati MJ, Rao PN, Grass F, Rao KW, Phelan MC, Cosper P, Carroll A, Elder F, Smith J, Higgins MD, Lanman JT, Higgins R, Butler M, Luthardt F, Keitges E, Brown J, Jackson-Cook C, Schwartz S, Van Dyke DL, Palmer CG. A review of 446 paracentric inversions with presentation of 120 new cases. Am J Med Genet. 1995; 55:171-87.
     View PubMed
113. Shaffer LG, McCaskill C, Han JY, Choo KH, Cutillo DM, Donnenfeld AE, Weiss L, Van Dyke DL. Molecular characterization of de novo secondary trisomy 13. Am J Hum Genet. 1994 Nov; 55(5):968-74.
     View PubMed
114. Wiktor A, Feldman GL, Kratkoczki P, Ditmars DM Jr, Van Dyke DL. 10p duplication characterized by fluorescence in situ hybridization. Am J Med Genet. 1994 Sep 1; 52(3):315-8.
     View PubMed
115. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chrom Cancer. 1994 Mar; 9(3):192-206.
     View PubMed
116. Migeon BR, Luo S, Stasiowski BA, Jani M, Axelman J, Van Dyke DL, Weiss L, Jacobs PA, Yang-Feng TL, Wiley JE. Deficient transcription of XIST from tiny ring X chromosomes in females with severe phenotypes. Proc Natl Acad Sci U S A. 1993 Dec 15; 90(24):12025-9.
     View PubMed
117. Zenger-Hain JL, Van Dyke DL, Wiktor A, Walker H, Feldman GL. Inverted duplication of chromosome 5p14p15.3 confirmed with in situ hybridization. Am J Med Genet. 1993 Dec 1; 47(8):1198-201.
     View PubMed
118. Carey TE, Van Dyke DL, Worsham MJ. Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res. 1993 Nov-Dec; 13(6B):2561-7.
     View PubMed
119. Zenger-Hain JL, Wiktor A, Goldman J, Van Dyke DL, Weiss L. X-inactivation pattern in an Ullrich-Turner syndrome patient with a small ring X and normal intelligence. Am J Med Genet. 1993 Sep 15; 47(4):490-3.
     View PubMed
120. Feldman GL, Weiss L, Phelan MC, Schroer RJ, Van Dyke DL. Inverted duplication of 8p: ten new patients and review of the literature. Am J Med Genet. 1993 Sep 15; 47(4):482-6.
     View PubMed
121. Worsham MJ, Carey TE, Benninger MS, Gasser KM, Kelker W, Zarbo RJ, Van Dyke DL. Clonal cytogenetic evolution in a squamous cell carcinoma of the skin from a xeroderma pigmentosum patient. Genes Chrom Cancer. 1993 Jul; 7(3):158-64.
     View PubMed
122. Zenger-Hain JL, Roberson J, Van Dyke DL, Weiss L. Interstitial deletion of chromosome 10, del(10) (q11.2q22.1) in a boy with developmental delay and multiple congenital anomalies. Am J Med Genet. 1993 Jun 1; 46(4):438-40.
     View PubMed
123. Migeon BR, Luo S, Stasiowski BA, Jani M, Axelman J, Van Dyke DL, Weiss L, Jacobs PA, Yang-Feng TL, Wiley JE. Deficient transcription of XIST in individuals with tiny ring X chromosomes and severe phenotypes: implications for the role of XIST in X inactivation. Proc Nat Acad Sci (USA). 1993; 90: 12025-9.
     
124. Wiktor A, Van Dyke DL, Weiss L. Characterization of a de novo 48,XX,+r(X),+r(17) by in situ hybridization in a patient with neurofibromatosis (NF1). Am J Med Genet. 1993 Jan 1; 45(1):22-4.
     View PubMed
125. Carey TE, Worsham MJ, Van Dyke DL. Chromosomal biomarkers in the clonal evolution of head and neck squamous neoplasia. J Cell Biochem Suppl. 1993; 17F:213-22.
     View PubMed
126. Worsham MJ, Benninger MJ, Zarbo RJ, Carey TE, Van Dyke DL. Deletion 9p22-pter and loss of Y as primary chromosome abnormalities in a squamous cell carcinoma of the vocal cord. Genes Chromosomes Cancer. 1993 Jan; 6(1):58-60.
     View PubMed
127. Van Dyke DL, Wiktor A, Palmer CG, Miller DA, Witt M, Babu VR, Worsham MJ, Roberson JR, Weiss L. Ullrich-Turner syndrome with a small ring X chromosome and presence of mental retardation. Am J Med Genet. 1992 Aug 1; 43(6):996-1005.
     View PubMed
128. Falik-Borenstein TC, Pribyl TM, Pulst SM, Van Dyke DL, Weiss L, Chu ML, Kraus J, Marshak D, Korenberg JR. Stable ring chromosome 21: molecular and clinical definition of the lesion. Am J Med Genet. 1992 Jan 1; 42(1):22-8.
     View PubMed
129. Worsham MJ, Van Dyke DL, Grenman SE, Grenman R, Hopkins MP, Roberts JA, Gasser KM, Schwartz DR, Carey TE. Consistent chromosome abnormalities in squamous cell carcinoma of the vulva. Genes Chrom Cancer. 1991 Nov; 3(6):420-32.
     View PubMed
130. Bradford CR, Kimmel KA, Van Dyke DL, Worsham MJ, Tilley BJ, Burk D, del Rosario F, Lutz S, Tooley R, Hayashida DJ, et al. 11p deletions and breakpoints in squamous cell carcinoma: association with altered reactivity with the UM-E7 antibody. Genes Chromosomes Cancer. 1991 Jul; 3(4):272-82.
     View PubMed
131. Tazelaar J, Roberson J, Van Dyke DL, Babu VR, Weiss L. Mother and son with deletion of 3p25-pter. Am J Med Genet. 1991 May 1; 39(2):130-2.
     View PubMed
132. Van Dyke DL, Wiktor A, Roberson JR, Weiss L. Mental retardation in Turner syndrome. J Pediatr. 1991 Mar; 118(3):415-7.
     View PubMed
133. Babu VR, Miles BJ, Cerny JC, Weiss L, Van Dyke DL. Cytogenetic study of four cancers of the prostate. Cancer Genet Cytogenet. 1990 Aug 1; 48(1):83-7.
     View PubMed
134. Bodrug SE, Roberson JR, Weiss L, Ray PN, Worton RG, Van Dyke DL. Prenatal identification of a girl with a t(X;4)(p21;q35) translocation: molecular characterisation, paternal origin, and association with muscular dystrophy. J Med Genet. 1990 Jul; 27(7):426-32.
     View PubMed
135. Nowinski GP, Van Dyke DL, Tilley BC, Jacobsen G, Babu VR, Worsham MJ, Wilson GN, Weiss L. The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive history. Am J Hum Genet. 1990 Jun; 46(6):1101-11.
     View PubMed
136. Grenman SE, Van Dyke DL, Worsham MJ, England B, McClatchey KD, Hopkins M, Babu VR, Grenman R, Carey TE. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B. Int J Cancer. 1990 May 15; 45(5):920-7.
     View PubMed
137. Grenman SE, Worsham MJ, Van Dyke DL, England B, McClatchey KD, Babu VR, Roberts JA, Maenpaa J, Carey TE. Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line. Gynecol Oncol. 1990 May; 37(2):188-99.
     View PubMed
138. Raman BK, Janakiraman N, Raju UR, Carey J, Babu VR, Van Dyke DL, Van Slyck EJ. Osteomyelosclerosis with granulocytic sarcoma of chest wall. Morphological, ultrastructural, immunologic, and cytogenetic study. Arch Path Lab Med. 1990 Apr; 114(4):426-9.
     View PubMed
139. Carey TE, Van Dyke DL, Worsham MJ, Bradford CR, Babu VR, Schwartz DR, Hsu S, Baker SR. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B. Cancer Res. 1989 Nov 1; 49(21):6098-107.
     View PubMed
140. Robinow M, Haney N, Chen H, Sorauf T, Van Dyke DL, Babu VR, Powell S, Maliszewski W, Guerin S, Landers JW. Secondary trisomy or mosaic "tetrasomy" 8p. Am J Med Genet. 1989 Mar; 32(3):320-4.
     View PubMed
141. Worsham MJ, Miller DA, Devries JM, Mitchell AR, Babu VR, Surli V, Weiss L, Van Dyke DL. A dicentric recombinant 9 derived from a paracentric inversion: phenotype, cytogenetics, and molecular analysis of centromeres. Am J Hum Genet. 1989 Jan; 44(1):115-23.
     View PubMed
142. Jackson CE, Van Dyke DL, Talpos GB, Norum RA, Tashjian AH Jr. MEN-2 tumor associations suggest a linear order of specific endocrine tumor genes. Horm Metab Res Suppl. 1989; 21:9-12.
     View PubMed
143. Grenman SE, Van Dyke DL, Worsham MJ, del Rosario F, Roberts JA, McClatchey KD, Schwartz DR, Babu VR, Carey TE. UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer. Cancer Res. 1988 Apr 1; 48(7):1864-73.
     View PubMed
144. Forsythe MG, Walker H, Weiss L, Roberson JR, Worsham MJ, Babu VR, Van Dyke DL. Duplication and deletion 11q23-q24 recombinants in two offspring of an intrachromosomal insertion ("shift") carrier. Henry Ford Hosp Med J. 1988; 36(4):183-6.
     View PubMed
145. Babu VR, Lutz MD, Miles BJ, Farah RN, Weiss L, Van Dyke DL. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology. Cancer Res. 1987 Dec 15; 47(24 Pt 1):6800-5.
     View PubMed
146. Van Dyke DL, Worsham M, Weiss L. The human inactivated X chromosome folds in early metaphase, prometaphase, and prophase. Hum Genet. 1987 Sep; 77(1):57-9.
     View PubMed
147. Van Dyke DL, Babu VR, Weiss L. Parental age, and how extra isochromosomes (secondary trisomy) arise. Clin Genet. 1987 Jul; 32(1):75-9.
     View PubMed
148. Babu VR, Van Dyke DL, Flejter WL, Jackson CE. Chromosome 20 deletion in multiple endocrine neoplasia type 2: expanded double-blind studies. Am J Med Genet. 1987 Jul; 27(3):739-48.
     View PubMed
149. Kurtzman DN, Van Dyke DL, Rich CA, Weiss L. Duplication 3p21----3pter and cyclopia. Am J Med Genet. 1987 May; 27(1):33-7.
     View PubMed
150. Gaba AR, Van Dyke DL, Weiss L. Dysgenetic male pseudohermaphroditism in a 45,X/46,X,del(Y)(q11.1) mosaic infant. Am J Med Genet. 1987 Mar; 26(3):545-9.
     View PubMed
151. Stoffer SS, Van Dyke DL, Bach JV, Szpunar W, Weiss L. Familial papillary carcinoma of the thyroid. Am J Med Genet. 1986 Dec; 25(4):775-82.
     View PubMed
152. Flejter WL, Van Dyke DL, Weiss L. Location of the X inactivation center in primates and other mammals. Hum Genet. 1986 Sep; 74(1):63-6.
     View PubMed
153. Maeda K, Hawkins ET, Oh HK, Kini SR, Van Dyke DL. Malignant lymphoma in transplanted renal pelvis. Arch Path Lab Med. 1986 Jul; 110(7):626-9.
     View PubMed
154. Van Dyke DL, Flejter WL, Worsham MJ, Roberson JR, Higgins JV, Herr HM, Knuutila S, Wang N, Babu VR, Weiss L. A practical metaphase marker of the inactive X chromosome. Am J Hum Genet. 1986 Jul; 39(1):88-95.
     View PubMed
155. Van Dyke DL, Worsham MJ, Fisher LJ, Weiss L. The centromere index and relative length of human high-resolution G-banded chromosomes. Hum Genet. 1986 Jun; 73(2):130-2.
     View PubMed
156. Van Dyke DL, Weiss L. Maternal effect on intelligence in fragile X males and females. Am J Med Genet. 1986 Jan-Feb; 23(1-2):723-37.
     View PubMed
157. Maeda K, VanSlyck EJ, VanDyke DL. Multiple myeloma terminating in acute eosinophilic leukemia. Cancer Genet Cytogenet. 1985 Mar 1; 16(1):81-9.
     View PubMed
158. Stanley WS, Barr M Jr, Hensinger R, Ruby SG, Van Dyke DL, Weiss L. Asymmetric skeletal anomalies in siblings. Clin Genet. 1984 Jun; 25(6):533-7.
     View PubMed
159. Babu VR, Van Dyke DL, Jackson CE. Chromosome 20 deletion in human multiple endocrine neoplasia types 2A and 2B: a double-blind study. Proc Natl Acad Sci U S A. 1984 Apr; 81(8):2525-8.
     View PubMed
160. Mu Y, Van Dyke DL, Weiss L, Olgac S. De novo direct tandem duplication of the proximal long arm of chromosome 2: 46,XX,dir dup(2)(q11 X 2q14 X 2). J Med Genet. 1984 Feb; 21(1):57-8.
     View PubMed
161. Flejter WL, Van Dyke DL, Weiss L. Bends in human mitotic metaphase chromosomes, including a bend marking the X-inactivation center. Am J Hum Genet. 1984 Jan; 36(1):218-26.
     View PubMed
162. Van Dyke DL, Babu VR, Jackson CE. Chromosomes in multiple endocrine neoplasia type 2 syndromes. Henry Ford Hosp Med J. 1984; 32(4):266-8.
     View PubMed
163. Jackson CE, Van Dyke DL. Chromosome instability in medullary carcinoma of the thyroid. World J Surg. 1984; 8:491-2.
     View PubMed
164. Worsham MJ, Van Dyke DL. A fast and consistent C-banding technique. Mammal Chromosome Newsl. 1984; 25:69-71.
     View PubMed
165. Talpos GB, Jackson CE, Yott JB, Van Dyke DL. Phenotype mapping of the multiple endocrine neoplasia type II syndrome. Surgery. 1983 Oct; 94(4):650-4.
     View PubMed
166. Van Dyke DL, Miller MJ, Weiss L. The origin of inverted tandem duplications, and phenotypic effects of tandem duplication of the X chromosome long arm. Am J Med Genet. 1983 Jul; 15(3):441-50.
     View PubMed
167. Van Dyke DL, Weiss L, Roberson JR, Babu VR. The frequency and mutation rate of balanced autosomal rearrangements in man estimated from prenatal genetic studies for advanced maternal age. Am J Hum Genet. 1983 Mar; 35(2):301-8.
     View PubMed
168. Van Dyke DL, Weiss L, Roberson JR. The frequency of balanced autosomal rearrangements in man estimated from prenatal genetic studies for advanced maternal age. Am J Hum Genet. 1983; 35:301-308.
     
169. Haseltine FP, Lynch VA, Van Dyke DL, Breg WR, Francke U. H-Y antigen expression in patients with X-autosomal translocations and gonadal dysgenesis. Am J Med Genet. 1982 Oct; 13(2):115-23.
     View PubMed
170. Gaba AR, Anderson GJ, VanDyke DL, Chason JL. Alobar holoprosencephaly and otocephaly in a female infant with a normal karyotype and placental villitis. J Med Genet. 1982 Feb; 19(1):78.
     View PubMed
171. Magenis RE, Webb MJ, McKean RS, Tomar D, Allen LJ, Kammer H, Van Dyke DL, Lovrien E. Translocation(X;Y)(p22.33;p11.2) in XX males: etiology of male phenotype. Hum Genet. 1982; 62(3):271-6.
     View PubMed
172. Van Dyke DL, Abraham JP, Maeda K, Weiss L, Poel M. Multiple active X chromosomes in myelofibrosis with myeloid metaplasia. Cancer Genet Cytogenet. 1981 Mar; 3(2):137-44.
     View PubMed
173. Melnyk AR, Weiss L, Van Dyke DL, Jarvi P. Malformation syndrome of duplication 12q24.1 leads to qter. Am J Med Genet. 1981; 10(4):357-65.
     View PubMed
174. Lee CY, Madrazo BL, Van Dyke DL, Smith J. Prenatal diagnosis of fetal cystic hygromas associated with generalized lymphangiectasis. Henry Ford Hosp Med J. 1981; 29(2):93-6.
     View PubMed
175. Van Dyke DL, Fluharty AL, Schafer IA, Shapiro LJ, Kihara H, Weiss L. Prenatal diagnosis of Maroteaux-Lamy syndrome. Am J Med Genet. 1981; 8(2):235-42.
     View PubMed
176. Van Dyke DL, Weiss L, Clark J, Worsham MJ, Beisel JB. Culture and karyotyping of amniotic fluid cells. J Histotechnol. 1980; 3:148-51.
     View PubMed
177. Kini KR, Van Dyke DL, Weiss L, Logan MS. Ring chromosome 6: case report and review of literature. Hum Genet. 1979; 50(2):145-9.
     View PubMed
178. Norum RA, Van Dyke DL, Weiss L. Deletion mapping of Esterase D (EsD) to chromosome 13q12.5 - q21.1. Cytogenet Cell Genet. 1979; 25:192.
     View PubMed
179. Klugo R, Van Dyke DL, Weiss L. Cytogenic studies of cryptorchid testes. Urology. 1978 Mar; 11(3):255-6.
     View PubMed
180. Van Dyke DL, Palmer CG, Nance WE, Yu PL. Chromosome polymorphism and twin zygosity. Am J Hum Genet. 1977 Sep; 29(5):431-7.
     View PubMed
181. Pai GS, Leach DC, Weiss L, Wolf C, Van Dyke DL. Thyroid abnormalities in 20 children with Turner syndrome. J Pediatr. 1977 Aug; 91(2):267-9.
     View PubMed
182. Van Dyke DL, Weiss L, Logan M, Pai GS. The origin and behavior of two isodicentric bisatellited chromosomes. Am J Hum Genet. 1977 May; 29(3):294-300.
     View PubMed
183. Van Dyke DL. Bibliography of human chromosome polymorphism. Mammalian Chromosome Newsletter. 1977; 18:85-119.
     
184. Van Dyke DL, Bennett J. Mite elimination from stock cultures. Drosophila Inform Serv. 1971; 46:156.
     View PubMed
185. Bennett J, Van Dyke DL. Improved food medium. Drosophila Inform Serv. 1971; 46:160.
     View PubMed